H
Harvest
Tax-loss replacement research
BIIB
Biogen Inc.
Health CareBiotechnologyBiotechnology
28 stocks · 12 ETFs
data as of Aug 24, 2026
REPLACEMENT RESEARCH

Tax-loss harvesting alternatives for BIIB

Among the 28 Biotechnology peers screened, AMGN (Amgen Inc.) has tracked BIIB most closely over the past year, with a return correlation of 0.50. The strongest fund stand-in is IYH (iShares US Healthcare ETF) at 0.56 over the past year. Correlations are computed from daily closing-price returns aligned by trading day.

Run this search live in the Screener →
STOCKS

Single-name peers

TickerNameSub-industry1Y3Y5Y10Y
AMGNAmgen Inc.Biotechnology0.500.510.420.40
VRTXVertex PharmaceuticalsBiotechnology0.460.340.350.32
INCYIncyteBiotechnology0.380.370.340.33
GILDGilead SciencesBiotechnology0.340.370.350.33
REGNRegeneron PharmaceuticalsBiotechnology0.340.420.360.35
BMRNBioMarin PharmaceuticalBiotechnology0.330.340.340.32
HALOHalozymeBiotechnology0.280.260.270.25
UTHRUnited TherapeuticsBiotechnology0.270.280.270.25
EXELExelixisBiotechnology0.270.220.250.26
NBIXNeurocrine BiosciencesBiotechnology0.250.250.250.26
KRYSKrystal BiotechBiotechnology0.220.270.170.16
CYTKCytokineticsBiotechnology0.220.210.220.23
ROIVRoivant SciencesBiotechnology0.210.260.20
MRNAModerna Inc.Biotechnology0.210.240.200.15
SRPTSarepta TherapeuticsBiotechnology0.200.210.210.20
FTREFortreaBiotechnology0.190.240.23
RGENRepligenBiotechnology0.180.260.250.23
ARWRArrowhead PharmaceuticalsBiotechnology0.170.300.330.23
TGTXTG Therapeutics, Inc.Biotechnology0.170.170.220.19
HRMYHarmony Biosciences Holdings, Inc.Biotechnology0.170.210.23
VIRVir Biotechnology, Inc.Biotechnology0.170.230.190.13
LGNDLigand Pharmaceuticals, Inc.Biotechnology0.160.220.260.26
ALNYAlnylam PharmaceuticalsBiotechnology0.150.220.240.23
VCELVericelBiotechnology0.140.240.280.18
PTGXProtagonist Therapeutics, Inc.Biotechnology0.090.180.160.11
XNCRXencor IncBiotechnology0.090.250.280.27
ADMAADMA Biologics, Inc.Biotechnology0.060.110.190.11
RCUSArcus Biosciences, Inc.Biotechnology0.030.230.250.20
ETFS

Fund stand-ins

An ETF is generally not 'substantially identical' to a single stock, which is why funds are the standard wash-sale-aware replacement.

TickerNameFocusMatch1Y3Y5Y10Y
IYHiShares US Healthcare ETFHealth Care SectorSECTOR0.560.570.520.48
XLVHealth Care Select Sector SPDRHealth Care SectorSECTOR0.550.560.510.47
FHLCFidelity MSCI Health Care ETFHealth Care SectorSECTOR0.550.580.530.48
VHTVanguard Health Care ETFHealth Care SectorSECTOR0.550.570.520.48
PPHVanEck Pharma ETFPharmaceuticalsINDUSTRY0.530.540.490.44
IBBiShares Biotechnology ETFBiotechnologyINDUSTRY0.480.580.540.52
IHEiShares US Pharmaceuticals ETFPharmaceuticalsINDUSTRY0.480.520.470.43
XBISPDR S&P Biotech ETFBiotechnology (Equal Wt)INDUSTRY0.320.450.460.42
IHIiShares Medical Devices ETFMedical DevicesSUB-IND0.270.360.370.34
XPHSPDR S&P PharmaceuticalsPharmaceuticals (Equal Wt)INDUSTRY0.260.430.440.40
IHFiShares Health Care ProvidersHealth Care ProvidersINDUSTRY0.230.270.330.34
ARKGARK Genomic Revolution ETFGenomics (Active)INDUSTRY0.210.350.370.34
NEXT STEPS

Harvesting a loss in BIIB?

RELATED

Replacement research for BIIB's peers

Browse all tickers →

Method: Pearson correlation of daily closing-price returns, Yahoo Finance data, series aligned by trading day, refreshed weekly. A cell is blank when overlapping history covers less than 60% of its window. Correlation is descriptive, not predictive. Wash-sale treatment depends on facts and circumstances — confirm with a tax professional. Not investment advice.